Augmentation of insulin-stimulated ANP release through tyrosine kinase and PI 3-kinase in diabetic rats

Bai, Guang Yi; Piao, Feng Lian; Kim, Sun Young; Yuan, Kuichang; Kim, Sung Zoo; Kim, Suhn Hee

doi:10.1016/j.peptides.2006.05.014

Cited by 2 publications

(1 citation statement)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the mRNA expression levels of ANP and BNP have been observed to be upregulated in cardiac tissue from STZ-induced diabetic animals (12,19,25). Acute hyperglycemia has also been found to stimulate the secretion of ANP in cardiac tissues (26). By contrast, the cardiac mRNA expression of CNP is decreased in STZ-induced diabetic rats (12).…”

Section: A B a Bmentioning

confidence: 98%

Characteristics of dendroaspis natriuretic peptide and its receptor in streptozotocin-induced diabetic rats

Park

Kim

et al. 2015

Molecular Medicine Reports

Self Cite

View full text Add to dashboard Cite

Dendroaspis natriuretic peptide (DNP) shares a functionally important sequence homology with other natriuretic peptides. However, the characteristics of DNP and its receptor in the context of diabetes remafin to be fully elucidated. In the present study, alterations in the plasma levels and tissue contents of DNP and the properties of its receptor in diabetic rats, induced by streptozotocin (STZ) injection, were investigated. The plasma levels of DNP were 90.01 ± 4.12 and 196.68 ± 5.60 pg/ml in the control and STZ-induced diabetic rats, respectively. The tissue contents of DNP in the cardiac atrium, ventricle, renal cortex and inner medulla of the STZ-induced diabetic rats were also significantly increased compared with the control rats. Specific (125)I-DNP-binding sites were located predominantly in the glomeruli and inner medulla of the rat kidney. In the glomeruli of the kidney, the apparent dissociation constants (Kd) of (125)I-DNP in the control and STZ-induced diabetic rats were 0.41 ± 0.03 and 0.56 ± 0.06 nM, respectively. The maximum binding capacities (Bmax) of (125)I-DNP in control and STZ-induced diabetic rats were 2.98 ± 0.21 and 6.22 ± 1.06 fmol/mg protein, respectively. However, no differences were observed in the apparent Kd and Bmax of (125)I-DNP in the inner medulla of the kidney between the control and STZ-induced diabetic rats. In the glomerular and inner medullary kidney membranes, DNP stimulated the production of cyclic guanosine monophosphate (cGMP) in a dose-dependent manner. The magnitude of cGMP production in glomerular membranes was greater in the STZ-induced diabetic rats, whereas the magnitude of cGMP production in the inner medullary membranes was lower in the STZ-induced diabetic rats compared with the control rats. These results indicated that STZ-induced diabetes modulate DNP and its receptor, and also suggested that modulation of the DNP system is involved in the renal function of diabetic animals via the intracellular domain of the kidney NP receptor.

show abstract